Brain Tumor Trials Collaborative

The mission of the Brain Tumor Trials Collaborative (BTTC) is to develop and perform state-of-the-art clinical trials in a collaborative and collegial environment, advancing treatments for patients with brain tumors, merging good scientific method with concern for patient well-being and outcome.


  • About

    The BTTC was created in 2003 as a network of medical centers with the expertise and the desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors. This network of institutions allows patients across a broad geographic range to participate in cutting-edge clinical trials and more rapidly determine the benefits of various therapies.

  • BTTC Clinical Trials

    The current treatment of malignant gliomas, the most common brain tumor in adults, remains challenging and less effective than desired. The BTTC has several trials that are either open or in development. These trials hope to deliver results that provide a more effective treatment therapy in controlling the tumor and increasing survival.

  • BTTC Doctors and Institutions

    Each of the participating BTTC institutions are committed to discovering new and effective therapies for the treatment of patients with brain tumors with compassion and understanding. The doctors who are participating in the BTTC are experts in their respective fields.